| 商品名 | 申请号 | 产品号 | 申请类型 | 活性成分 | 剂型/给药途径 | 规格/剂量 | RLD | RS | 申请号原始批准/暂定批准日期 | 产品号批准日期 | 申请人 | 市场状态 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SACUBITRIL AND VALSARTAN | 213680 | 003 | ANDA | SACUBITRIL; VALSARTAN | TABLET;ORAL | 97MG;103MG | No | No | 2024/08/30 | 2024/08/30 | BIOCON PHARMA | Prescription |
| SACUBITRIL AND VALSARTAN | 213764 | 001 | ANDA | SACUBITRIL; VALSARTAN | TABLET;ORAL | 24MG;26MG | No | No | 2024/09/16 | 2024/09/16 | ALKEM LABS LTD | Prescription |
| SACUBITRIL AND VALSARTAN | 213764 | 002 | ANDA | SACUBITRIL; VALSARTAN | TABLET;ORAL | 49MG;51MG | No | No | 2024/09/16 | 2024/09/16 | ALKEM LABS LTD | Prescription |
| SACUBITRIL AND VALSARTAN | 213764 | 003 | ANDA | SACUBITRIL; VALSARTAN | TABLET;ORAL | 97MG;103MG | No | No | 2024/09/16 | 2024/09/16 | ALKEM LABS LTD | Prescription |
| SACUBITRIL AND VALSARTAN | 213728 | 001 | ANDA | SACUBITRIL; VALSARTAN | TABLET;ORAL | 24MG;26MG | No | No | 2024/10/16 | 2024/10/16 | MACLEODS PHARMS LTD | Prescription |
| SACUBITRIL AND VALSARTAN | 213728 | 002 | ANDA | SACUBITRIL; VALSARTAN | TABLET;ORAL | 49MG;51MG | No | No | 2024/10/16 | 2024/10/16 | MACLEODS PHARMS LTD | Prescription |
| SACUBITRIL AND VALSARTAN | 213728 | 003 | ANDA | SACUBITRIL; VALSARTAN | TABLET;ORAL | 97MG;103MG | No | No | 2024/10/16 | 2024/10/16 | MACLEODS PHARMS LTD | Prescription |